Can-Fite BioPharma Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Can-Fite BioPharma Ltd. generated cash of -$8,440,000, which is more than the previous year. Cash used in financing activities reached the amount of $9,144,000 last year. Net change in cash is therefore $1,300,000.
Cash Flow
| 2014 | -7.32M | -9.50K | 11.47M |
|---|---|---|---|
| 2015 | -4.65M | -42.78K | 12.38M |
| 2016 | -8.92M | -10.39K | 0 |
| 2017 | -9.52M | -29.63K | 4.88M |
| 2018 | -4.15M | -33K | 4.38M |
| 2019 | -10.83M | -253K | 10.16M |
| 2020 | -12.06M | -26K | 17.68M |
| 2021 | -9.85M | -14.51M | 20.45M |
| 2022 | -10.80M | 9.50M | 20.45M |
| 2023 | -8.44M | 498K | 9.14M |
CANF Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 2.97M | 4.39M | 8.26M | 2.69M | 3.61M | 3.50M | 8.97M | 17.16M | 9.24M | 5.33M |
Operating activities | ||||||||||
Net income | -7.63M | -10.17M | -12.61M | -14.44M | -12.62M | -6.57M | -4.98M | -7.02M | -5.06M | -6.29M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 15K | 14K | 14K | 12K | 14K | 14K | 19.85K | 18.45K | 16.39K | 12.07K |
Stock-based compensation expense | 261K | 263K | 466K | 355K | 385K | 535K | 195.07K | 309K | 109K | 211.99K |
| Deferred income tax benefit | 261K | 263K | 466K | 355K | 385K | 535K | 195.07K | 309K | 109K | 211.99K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 2.72M | 270K | -853K | -1.15M | -1.36M | 255.14K | -303.29K |
Inventories | 0 | 0 | 0 | 1.27M | -316K | 125K | -4 | 0 | 9 | 0 |
Accounts payable | -469K | -58K | 393K | -1.59M | 1.08M | 644K | -964.15K | 591.95K | 78.9K | -658.46K |
Cash generated by operating activities | -8.44M | -10.80M | -9.85M | -12.06M | -10.83M | -4.15M | -9.52M | -8.92M | -4.65M | -7.32M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | -14.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -2K | -9K | -11K | -26K | -3K | -33K | -6.90K | -10.39K | -45.34K | -9.50K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | -22K | 0 | 2.57K | 0 |
Cash generated by investing activities | 498K | 9.50M | -14.51M | -26K | -253K | -33K | -29.63K | -10.39K | -42.78K | -9.50K |
Financing activities | ||||||||||
Common Stock Issued | 9.14M | 0 | 20.45M | 17.68M | 10.16M | 4.38M | 4.47M | 0 | 12.38M | 11.47M |
Payments for dividends | 0 | -2.59M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 9.14M | 20.45M | 20.45M | 17.68M | 10.16M | 4.38M | 4.88M | 0 | 12.38M | 11.47M |
Net Change In Cash | 1.3M | -1.41M | -3.87M | 5.57M | -918K | 110K | -5.48M | -9.05M | 7.66M | 3.93M |
Cash at end of period | 4.27M | 2.97M | 4.39M | 8.26M | 2.69M | 3.61M | 3.49M | 8.11M | 16.91M | 9.26M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |